Lin Xu

15PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 05, 2026
Hypoxic niche drives lineage imbalance and early tumorigenesis in EGFR-mutant lung cancer.

|Nov 26, 2025
SKA3-mediated hypoxia tolerance and metabolic reprogramming promote liver metastasis in lung adenocarcinoma.

Zedong Sun, Minmin Zhou, Ningdan Song

|Nov 10, 2025
The N6-methyladenosine-mediated cLMNB1 degrades FGFR4 to overcome osimertinib resistance in non-small cell lung cancer.

Yuxian Qian, Hui Wang, Yipeng Feng

|Aug 25, 2025
Targeting LINC01711 in FAP+ cancer-associated fibroblasts overcomes lactate-mediated immunosuppression and enhances anti-PD-1 efficacy in lung adenocarcinoma.

Qinglin Wang, Yuxiang Sun, Jianyu Li

|Feb 12, 2025
STAT3 Inhibition Prevents Adaptive Resistance and Augments NK Cell Cytotoxicity to KRASG12C Inhibitors in Nonsmall Cell Lung Cancer.

Zehao Pan, Yuxian Qian, Yajing Wang

|Jul 23, 2024
The recruitment of CD8+ T cells through YBX1 stabilization abrogates tumor intrinsic oncogenic role of MIR155HG in lung adenocarcinoma.

Rutao Li, Yijian Zhang, Anpeng Wang

Pageof 3

Frequent Collaborators

6 joint publications

Feng Jiang

5 joint publications

Hui Wang

5 joint publications

Gaochao Dong

2 joint publications

Yingkuang Liang